Ichan School of Medicine: A Novel Monoclonal Antibody Therapy Cuts LDL Cholesterol by Half in a High-Risk Patient Population, Study Shows

Press/Media

Period15 Nov 2020

Media coverage

1

Media coverage

  • TitleIchan School of Medicine: A Novel Monoclonal Antibody Therapy Cuts LDL Cholesterol by Half in a High-Risk Patient Population, Study Shows
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date15/11/20
    PersonsRobert Sidney Rosenson